0001104659-22-123637.txt : 20221201 0001104659-22-123637.hdr.sgml : 20221201 20221201154951 ACCESSION NUMBER: 0001104659-22-123637 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221201 DATE AS OF CHANGE: 20221201 EFFECTIVENESS DATE: 20221201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Serimmune Inc. CENTRAL INDEX KEY: 0001693808 IRS NUMBER: 464761259 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-409629 FILM NUMBER: 221438750 BUSINESS ADDRESS: STREET 1: 917 N. PATTERSON AVE. CITY: SANTA BARBARA STATE: CA ZIP: 93111 BUSINESS PHONE: (805) 451-5083 MAIL ADDRESS: STREET 1: 917 N. PATTERSON AVE. CITY: SANTA BARBARA STATE: CA ZIP: 93111 D/A 1 primary_doc.xml X0708 D/A LIVE 0001693808 Serimmune Inc. 150 CASTILIAN DRIVE, SUITE 100 GOLETA CA CALIFORNIA 93117 (805) 650-5229 DELAWARE None None Corporation true Malek Faham 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Executive Officer Director Patrick Daugherty C/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Bill Welch C/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Kristin Loomis 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Nicholas Naclerio C/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Biotechnology Decline to Disclose 06b true 0001104659-21-103418 2021-07-21 true true true Convertible Promissory Notes and the Equity Securities issuable upon conversion of such Notes false 0 13500000 9535454 3964546 false 3 0 0 0 false Serimmune Inc. /s/ Malek Faham Malek Faham Chief Executive Officer 2022-11-22